Correspondence simon.boulton@crick.ac.uk In Brief Bellelli et al. report that Pole4 deficiency in mice or POLE1 mutations in humans result in Pol Epsilon complex instability, replication stress, and inefficient origin activation. As a consequence, Pol Epsilon hypomorphic mice exhibit aberrant growth and development, lymphopenia, and tumor predisposition, which can be rescued by deleting p53.
INTRODUCTION
DNA replication in eukaryotes is performed by a large multisubunit machine, known as the replisome, which assembles at thousands of DNA replication origins in a cell-type-and developmental-stage-dependent manner (for review, see Mé chali, 2010) . Assembly of the eukaryotic replisome begins in G1 phase of the cell cycle with loading of inactive MCM2-7 double hexamers at origins (for review, see Masai et al., 2010) . At the G1-S transition, DDK-and CDK-dependent phosphorylation drives assembly of the CMG complex, composed of CDC45, MCM2-7, and GINS1-4, which is considered to form the processive replicative helicase (Ilves et al., 2010; Labib, 2010) . Two major DNA polymerases, Pold and Polε, are thought to replicate the lagging and leading strand, respectively (Nick McElhinny et al., 2008; Pursell et al., 2007) . In addition to its catalytic role, Polε is required for CMG formation and origin activation in budding yeast; while its N-terminal catalytic domain is dispensable for viability, deletion of its C-terminal structural domain is lethal in S. cerevisiae (Handa et al., 2012; Muramatsu et al., 2010; Sengupta et al., 2013; Yeeles et al., 2015) .
Mammalian Polε is composed of four subunits: POLE1, homolog of S. cerevisiae Pol2, contains polymerase and exonuclease activities (Lee et al., 1991; Syvaoja and Linn, 1989) ; POLE2, homolog of Dpb2, structurally links Polε to the CMG complex (Li et al., 1997; Sengupta et al., 2013) ; and two smaller subunits, POLE3 and POLE4, orthologs of Dpb4 and Dpb3, whose functions are unknown (Li et al., 2000) . Dpb3 and Dpb4 are non-essential in S. cerevisiae, with dpb3D and dpb4D yeast strains exhibiting increased mutation rates and defective S-phase progression, respectively (Araki et al., 1991; Ohya et al., 2000) . Both proteins harbor histone fold motifs of the H2A-H2B family, through which they are thought to interact with each other and increase Polε binding to double-stranded DNA and/or provide an interaction surface at the replication fork (Iida and Araki, 2004; Tackett et al., 2005; Tsubota et al., 2003) . Of note, Dpb4 and its human homolog POLE3 are also components of the budding yeast ISWI2/yCHRAC and the human hCHRAC chromatin remodeling complexes, respectively (Poot et al., 2000; Iida and Araki, 2004) . Studies in vitro using recombinant proteins have shown that yeast Polε lacking Dpb3 and Dpb4 exhibits reduced processivity on synthetic DNA substrates, which may explain the increased mutagenesis of dpb3D-dpb4D yeast strains (Aksenova et al., 2010) . Biochemical studies using reconstituted human Polε suggested that POLE3 and POLE4 bind to the catalytic subunit POLE1 at different sites compared to their yeast homologs and do not significantly contribute to the rate of DNA synthesis in vitro, which suggests that POLE3-POLE4 functions in higher eukaryotes might differ from budding yeast (Bermudez et al., 2011) .
Several clinically recognized human syndromes are caused by mutations in DNA replication genes, many of them presenting with growth failure and skeletal abnormalities, endocrine and/or immune dysfunctions, and heightened cancer risk (for review, see Jackson et al., 2014) . Recently, mutations of Polε subunits, POLE1 and POLE2, have been described in human patients suffering from immunodeficiency and growth restriction (Frugoni et al., 2016; Pachlopnik Schmid et al., 2012) . However, substantive biological and mechanistic insights into disease pathogenesis remain to be established. Moreover, mutations of POLE1 in proximity to the proofreading exonuclease domain have been identified in several neoplasias such as colorectal and endometrial cancer, which are associated with a peculiar hypermutator phenotype (Alexandrov et al., 2013; Campbell et al., 2017; Kandoth et al., 2013; Yang et al., 2013) .
To unravel the function of Polε accessory subunits in vertebrates, we report here the generation of a mouse knockout for the Pole4 gene and describe the functional characterization of primary cell lines from two human patients harboring destabilizing mutations in POLE1. While essential for embryonic development in a C57BL/6 inbred strain, we found that Pole4 knockout mice are viable in an outbred background, presenting with a multitude of developmental growth defects, including craniofacial and skeletal abnormalities and defective B and T cell maturation. Notably, these overlap with the clinical features observed in patients harboring POLE1/2 mutations. In addition, we show that Pole4 À/À mice and patient cells with POLE1 mutations exhibit Polε complex instability, which leads to inefficient origin activation, replicative damage, genome instability, and p53 activation. Surprisingly, removal of p53 is sufficient to rescue the complex array of developmental abnormalities in Pole4 À/À mice and restore lymphoid lineage differentiation. Despite this, p53 haploinsufficiency further exacerbates genetic instability and leads to accelerated tumorigenesis in the absence of POLE4. Collectively, our work defines a mouse model of Polε hypomorphy and extends the group of human genetic diseases at the cross-road of CMG activation and replication fork establishment, highlighting the intimate connection between replication origin activation, genome instability, and cancer development.
RESULTS

Pole4 Knockout Mice Are Viable in an Outbred Strain and Exhibit Phenotypes Similar to Human Patients with Mutations in POLE1 or POLE2
To investigate the role of DNA polymerase ε in a complex organism, we generated a Pole4-deficient mouse model in the inbred C57BL/6 genetic background from an existing EUCOMM embryonic stem cell line, Pole4 tm1(KOMP)Vlcg , in which most of the Pole4 gene has been replaced by a b-galactosidase-neomycin reporter cassette ( Figure 1A) . Sequencing of the first exon revealed that the deletion cassette is inserted 94 bp after the start of exon 1 ( Figure S1A ). Based on this information, we developed a genotyping strategy to detect wild-type (WT), heterozygous, and mutant alleles using a three-primer PCR. POLE4 protein was undetectable in mutant embryo extracts by immunoblotting and was reduced by $50% in heterozygous cells compared to WT ( Figure 1B ). Pole4 tm1(KOMP)Vlcg intercrosses in the C57BL/6 inbred background gave rise to only 1 viable animal out of 63 expected ( Figure S1B ). Further examination of Pole4 embryos in utero revealed that most embryos die with extensive developmental defects between 11.5 and 13.5 days postcoitum (dpc) ( Figure S1C ; data not shown). Unexpectedly, crossing the Pole4 tm1(KOMP)Vlcg allele into an FVB/sv129 outbred background resulted in viable Pole4 null mutant mice, albeit at lower than expected Mendelian ratios, corresponding to 9.3% compared to 25% expected ( Figure 1C) . In utero analysis of timed matings revealed that Pole4 lethality in the FVB/sv129 outbred background occurs between 13.5 dpc and birth. Pole4 mutant embryos in this outbred background showed no significant developmental abnormalities at 13.5 dpc with the exception of intrauterine growth retardation ( Figure 1D , left). At 13.5 and 15.5 dpc, mutant embryos were significantly smaller with a decreased weight (Figures 1D, middle, and S1D; at 13.5 dpc, Pole4 +/+ , 0.16 ± 0.022 g versus Pole4
, 0.12 ± 0.027 g; at 15.5 dpc, Pole4 +/+ , 0.42 ± 0.011 g versus Pole4
, 0.30 ± 0.0094 g, respectively). They also exhibited a significantly smaller mandible, tibia, and pelvis length relative to the femur length, whereas skull, humerus, and radius had a similar size compared to WT ( Figure S1E ). From 3 to 34 weeks postpartum, Pole4 mutants remained at lower weight and shorter length compared to their WT littermates (Figure 1D , right; data not shown), suggesting that these mice have a significant developmental growth defect. To investigate the source of these developmental issues, we proceeded to characterize the viable FVB/sv129 outbred Pole4 À/À animals.
Breeding experiments over a 5-month period involving a Pole4 À/À animal as one of the breeding pairs showed that these mice are subfertile, producing significantly less litters and a tendency for fewer pups ( Figure 1E , top). Breeding of heterozygous pairs resulted in an average of 26 litters with 202 pups (1.3 litters per 21-day-gestation interval and 11 pups per litters), whereas breeding involving one mutant in a pair produced only 15 litters with 118 pups (0.95 litters per 21-day-gestation interval and 7.5 pups per litters). Examination of the testes of Pole4-deficient neonatal mice revealed a marked reduction in the number of promyelocytic leukemia zinc-finger (PLZF)-positive cells per tubules compared to controls (6.8 ± 2.2 versus 4.1 ± 1.9), suggesting that the subfertility of Pole4 mutant is likely due to germ cell attrition ( Figure 1E , bottom). Detailed phenotypic characterization of adult Pole4 À/À mice revealed skeletal defects and craniofacial abnormalities. While acknowledging the morphological differences between mice and humans, we noted that similar bone dysplasia and facial dysmorphism have also been reported in human patients with mutations of the POLE1 and POLE2 genes (Frugoni et al., 2016; Pachlopnik Schmid et al., 2012; Thiffault et al., 2015) . In addition to this, we also noticed white patches on the belly, kinks and curls in their tails, and an unusual gait (Figure 1F) , which were evident in some, but not all, of the Pole4 À/À animals ( Figure S1F ). Micro-computed tomography (CT) scans revealed that the tail kinks or curls in the Pole4-deficient mice are caused by vertebrae fusions ( Figure 1G ), suggestive of a notochord formation defect (Farkas and Chapman, 2009) . Pole4 À/À mice had reduced brain weight, albeit with a relative normal ratio between whole body and brain size ( Figure 1H ; Pole4 +/+ , 0.48 ± 0.056 g versus Pole4 À/À , 0.35 ± 0.086 g). We also investigated the unusual gait of these mice by monitoring their ability to stay upright on a rotating rod. Pole4 mutant mice fell around 3 s earlier from the rod than their WT littermates (Figure 1I) , suggesting the Pole4 deficiency leads to loss of motor function/coordination in mice. Importantly, the latter did not worsen with age, suggesting that this ataxic phenotype is developmental in origin and not degenerative ( Figure S1G ). In line with a developmental defect, cerebellum sectioning of 3-month-old mutant mice showed a reduced cerebellum size and a severe foliation defect. Whereas WT mice presented with 7-10 lobules, only 3-6 lobules were detectable in the cerebellum of Pole4 À/À mice, suggesting that cerebellar development is impaired after loss of POLE4 ( Figure S1H ). This is further supported by the lengthening of the roof plate in embryos at 13.5 dpc, which results in defective midline fusion ( Figure S1I ). To determine the long-term effect of POLE4 loss in vivo, we conducted an aging study on 36 WT and 36 Pole4 À/À mice.
Pole4 deficiency did not lead to a reduction in lifespan ( Figure 1J ) but did result in increased incidence of lymphomas in the thymus (around 12% of Pole4-deficient mice compared to 4% WT mice) and mesenteric lymph nodes (23.5% in Pole4 À/À versus 7.7% in WT; Figure 1K ).
Loss of POLE4 Leads to Failed Lymphoid Progenitor Maturation and p53 Activation
Analysis of hematological parameters showed that Pole4-deficient mice exhibit leukopenia, with a 2.3-fold decrease in the number of white blood cells, moderate anemia, and thrombocytosis ( Figure 2A ). We subsequently discovered that leukopenia is caused by a lymphopenia associated with an increase in the proportion of granulocytes and monocytes ( Figure 2B ). To identify which subset of lymphocytes is affected, we performed flow cytometry analysis of Pole4 mice splenocytes. As shown in Figure 2C , Pole4 mutant mice showed a 5-fold decrease of CD4 + and CD8 + T lymphocytes and a 20-fold increase in the number of CD4 CD8 double-negative precursor cells, compared to WT controls. As maturation of the T cell precursors occurs in the thymus, we examined histological thymus sections from WT and Pole4 À/À mice ( Figure S2A ). We discovered that Pole4
thymus are devoid of cortex and are composed of medulla only structures, suggesting that T cell maturation is severely compromised upon POLE4 loss ( Figure S2A ). Indeed, around 80% of Pole4-deficient mice have absent or a structurally disorganized thymus ( Figure 2D ). Pole4 mutant mice also presented with an 8-fold reduction in the number of B cells, which tended to stay at an immature IgD-negative stage ( Figure 2E ). Mutant mice have a smaller spleen than WT animals and a smaller spleen weight compared to body weight (Figures 2F and S2B) . Histological examination of Pole4 À/À spleens revealed that more than 30% of mutant mice have spleens with inconspicuous and/or underdeveloped follicles, suggestive of impaired B cell maturation. In addition, mesenteric lymph nodes showed a disorganized structure with underdeveloped follicles ( Figure S2C ). As lymphoid organs are originally seeded by hematopoietic stem cells (HSCs), we analyzed the HSC compartment in the bone marrow of Pole4-deficient mice. Contrary to expectation, loss of POLE4 led to a 3.5-fold increase in the number of HSCs compared to WT littermates as seen by the increase in the number of LSK (Lin By performing cobblestone area forming assays to assess the differentiation abilities of HSCs, we noticed that Pole4-deficient HSCs retain the ability to differentiate properly to common myeloid progenitors, notably into granulocytes and monocytes progenitors ( Figure S2D ), which is in accordance with the increase in the number of granulocytes and monocytes previously observed ( Figure 2B ). These results suggest that Pole4-deficient HSCs can differentiate into downstream progenitors, but longterm HSCs may either fail to self-renew to maintain adequate HSC numbers or die due to an increased apoptosis.
To distinguish between these possibilities, we assessed the levels of apoptosis and DNA damage during embryogenesis, particularly in the liver, which is one of the main hematopoietic organs during development. Pole4-deficient embryos (13.5 dpc) presented elevated p53 expression levels and increased cleaved caspase 3 (CC3) ( Figure 2H ). Immunohistochemistry experiments on 13.5 dpc embryos showed that apoptosis (p53 and CC3 staining) and DNA damage (as shown by gH2AX staining) are increased in both forebrain and liver (Figures 2I and S2E) in the Pole4 mutant, suggesting that HSCs likely die as a consequence of p53 activation and apoptosis. These data also suggest that the reduced growth and developmental alterations (such as dwarf-like craniofacial abnormalities and (I) Immunohistochemistry quantification of gH2AX, cleaved caspase 3, and p53 in forebrain, and liver section of 13.5 dpc embryos. Significance: t test.
skeletal abnormalities) observed in Pole4 À/À embryos and mice may be due to apoptosis-dependent elimination of cells during early stages of embryonic development, similar to that previously described in ATR-Seckel mice (Murga et al., 2009) .
DNA Polymerase ε Complex Destabilization Drives Replication Stress in Pole4 -/-Mouse Embryo Fibroblasts
To investigate the impact of Pole4 deficiency at a cellular level, we derived mouse embryonic fibroblasts (MEFs) from WT and Pole4 À/À embryos. Pole4-deficient MEFs exhibited reduced proliferative potential when grown under a standard 3T3 protocol and in low-oxygen (5%) conditions ( Figure S3A ). Furthermore, EdU/DAPI (5-ethynyl-2 0 -deoxyuridine/4 0 ,6-diamidino-2-phenylindole) flow cytometry and immunofluorescence analyses showed an increased proportion of Pole4 À/À cells in the G2 phase of the cell cycle as well as increased levels of the replicative stress markers 53BP1 and gH2AX ( Figures  S3B-S3D ). Polε has also been shown to be involved in activation of the intra-Sphase checkpoint in yeast (Lou et al., 2008; Navas et al., 1995) . However, we failed to detect a defect in Chk1 or H2AX phosphorylation after HU or UV treatment in cells lacking POLE4 ( Figure S3E ), suggesting that the checkpoint response remains intact.
To identify the possible source of replicative stress in Pole4
À/À cells, we first analyzed whole-cell extracts by immunoblotting for the levels of Polε, Pold, Pola, and other components of the replisome ( Figure 3A ). In contrast to controls, the levels of the major catalytic subunit of Polε, POLE1, were strongly decreased, corresponding to less than 5%-10% of WT levels. We also noticed a reduction, albeit to a lower level, of the second major subunit, POLE2 ( Figure 3A ). This finding differentiates the mammalian Polε complex from its yeast ancestor, in which the smallest subunits, Dpb3 and Dpb4, are dispensable for maintaining Pol2/ Dpb2 stability. This is also reminiscent of Pold3 deletion in mice, which severely affects the stability of the whole Pold complex, resulting in early embryonic lethality (Murga et al., 2016) .
In whole-cell extracts, loss of POLE4 did not significantly affect the levels of POLD1, POLD2, POLA1 (component of the Pola complex), or other major components of the replication machinery, such as GINS3, MCM2, and CDC45, which are essential components of the processive CMG helicase (Figure 3A) . In addition to this, transient knockdown of POLE4 in human HeLa cells was associated with loss of POLE3 expression and vice versa, which suggests that POLE3 and POLE4 are constitutive partners in mammalian cells and required for each other's stability ( Figure S3F ). Consistent with our cellular studies, we also observed a strong reduction of both POLE1 and POLE2 protein levels in extracts from testis of Pole4 À/À mice ( Figure 3B ); this indicates that the Pole4 knockout is a Polε hypomorphic mouse model, which may explain the subfertility observed in Pole4 À/À mice (Figure 1 ). Of note, while Pole4 +/À cells showed an $50% reduction of POLE4 protein compared to WT, levels of POLE1 were not significantly changed, potentially explaining the milder phenotype observed in Pole4 heterozygous mice, embryos, and cells ( Figures S3G-S3I ).
To investigate the levels and stoichiometry of protein complexes actively involved in DNA replication, we proceeded to analyze the levels of replication factors on chromatin in WT and Pole4-deficient MEFs ( Figure 3A , chromatin panel). Consistent with Polε complex hypomorphy, chromatin levels of POLE1 were severely decreased in the knockout cells; this was associated with a strong reduction in chromatin-bound POLE2 (compared to total extracts), which points to reduced levels of the whole Polε complex on chromatin. Other replication factors, such as PCNA and Pold subunits POLD1 and POLD2, as well as CDC45 and GINS3, were largely unaffected in the knockout cells ( Figure 3A , chromatin panel).
To distinguish between chromatin-bound proteins and proteins actively traveling with the replication fork, we employed SILAC (stable isotope labeling with amino acids in cell culture)-based proteomics coupled to iPOND (isolation of protein on nascent DNA strands) to quantitatively analyze the composition of replisomes from WT and Pole4 À/À MEFs (Dungrawala et al., 2015; Lopez-Contreras et al., 2013; Sirbu et al., 2011) . To this end, we EdU-pulse labeled WT and Pole4 À/À cells, grown in heavy and light media, respectively, and subjected them to iPOND and mass spectrometry analysis ( Figure S4A ). Despite the strong reduction in total and chromatin-bound levels of Polε subunits, we did not detect a major imbalance of polymerases at the replication fork, or the accumulation of other accessory TLS polymerases ( Figure 3C ; data not shown). Similar results were obtained from the reverse experiment in which WT and Pole4 À/À cells were grown in light and heavy media, respectively (Figures S4B and S4C) . Consistent with our SILAC-based quantitative measurements, iPOND western blot experiments showed no significant differences in POLE1 and POLE2 protein levels at active replication forks between Pole4-proficient and -deficient cells ( Figure 3D ). These data suggest that, once replication forks are established in Pole4 À/À cells, a
Polε complex composed of POLE1 and POLE2 remains stably associated with the replisome and that a POLE1/2 subcomplex is sufficient to initiate processive DNA replication. A possible explanation for the reduced levels and altered stoichiometry of chromatin-bound Polε complex in Pole4 À/À MEFs is that CDC45 and the GINS complex are recruited to DNA replication origins, but a functional CMG is not efficiently established, as recently showed by in vivo auxin-degron studies in S. cerevisiae (Miyazawa-Onami et al., 2017) . Consistent with this hypothesis, Pole4 À/À cells obtained from inbred C57BL/6 embryos showed significant reduction in the levels of PCNA and POLD1 with minimally affected levels of CDC45 and GINS proteins ( Figure S4D ). Furthermore, transient knockdown of POLE1 in human HeLa cells did not affect chromatin levels of CDC45 or GINS complex component GINS1 ( Figure S4E ). These data suggest that Polε hypomorphy might impair formation and/ or activation of a stable CMG complex, resulting in reduced DNA replication origin activation. Alternatively, reduced processivity, as observed in the yeast Pol2-Dpb2 subcomplex, lacking Dpb3 and Dpb4 (Aksenova et al., 2010) , could be the primary cause of replication stress and DNA damage accumulation observed in Pole4-deficient cells.
To study replication fork activation and progression at a single-molecule level, we incubated WT and Pole4 À/À cells with 5-chloro-2'-deoxyuridine (CldU) and then 5-iodo-2'-deoxyuridine (IdU) and monitored replication fork dynamics by fiber stretching assays (Bellelli et al., 2014; Figures 3E-3G) . This analysis revealed a significant increase in the frequency of asymmetric forks in Pole4 À/À cells when compared to WT controls ( Figure 3E ). Fork stalling events in response to replication stress are associated with dormant origin activation and a corresponding reduction of both IOD (inter-origin distance) and fork speed in mammalian cells, most likely due to compensation mechanisms based on titration of replication factors and deoxyribonucleoside triphosphate (dNTP) levels (for review, see Té cher et al., 2017) . Fiber stretching analysis revealed a modest increase in both IOD and fork speed distribution in Pole4 À/À MEFs compared to their WT counterparts ( Figures 3F and 3G ). The discrepancy between IOD, fork speed, and fork asymmetry observed in Pole4 À/À cells is reminiscent of that previously described in mouse cells harboring a Chaos3 allele of Mcm4 (Shima et al., 2007) , which exhibits fork asymmetry in the absence of reduced IOD due to extensive reduction of chromatin levels of MCM2-7 hexamers and reduced origin activation (Kawabata et al., 2011a) . In contrast to Mcm4 (Chaos3) , Polε hypomorphy was not associated with reduced levels of chromatin-bound MCM2-7 (Figure 3A) . Thus, we reasoned that Polε instability might lead to reduced stable CMG formation/activation and, as a consequence, to reduced or altered spatiotemporal activation of DNA replication origins. Consistent with this notion, we detected a significant reduction in the total number of initiation events in Pole4 À/À cells compared to WT ( Figure S4F ). Furthermore,
Pole4
À/À MEFs generated from the more severely affected C57BL/6 inbred background exhibited significantly higher replication fork extension rates when compared to their WT counterparts ( Figure S4G ). It was previously shown that IOD and fork speed distributions vary significantly between different mouse strains; for instance, MEFs from a C57BL/6 strain show reduced origin activation and a compensatory higher fork speed compared to cells from outbred genetic backgrounds (Kawabata et al., 2011b) . We speculate that this phenomenon might explain the embryonic lethality of the Pole4 knockout allele in the inbred C57BL/6 background (Figures 1 and S1 ). Collectively, these data suggest that the POLE3-POLE4 subcomplex, while playing an important role in maintaining Polε complex stability, is not required for maximal replication rate extension in vivo. Furthermore, our data suggest that loss of POLE4 leads to reduced and/or imbalanced origin firing potentially due to defective CMG complex formation and/or activation.
Polε Complex Instability and Replication Stress in POLE1 Patient-Derived Cells A number of human Mendelian disorders are caused by mutations in essential genes involved in distinct aspects of DNA replication (for review, see Jackson et al., 2014) . Whole-genome sequencing of two patients with microcephalic dwarfism, intrauterine growth retardation, immunodeficiency, and endocrine insufficiencies identified compound heterozygous mutations in POLE1 for the same intronic variant, c.168 + 32C > G, and a further mutation predicted to result in loss of POLE1 functional transcripts (C.L., J.E. Murray et al., unpublished data; see clinical synopsis in STAR Methods). Since intra-uterine growth retardation and marked reduction in postnatal size and lymphopenia are also seen in the Pole4 mouse model ( Figures  1 and 2 ), we hypothesized that this model would help in understanding the human disease pathogenesis. We therefore investigated whether POLE1 patient cells exhibit the same molecular defects as those observed in Pole4
To analyze the impact of POLE1 mutations on Polε subunits levels, DNA replication, and genome stability, primary dermal fibroblast lines were obtained from the newly identified patients (P1 and P2). Like Pole4 À/À cells, POLE1 patient-derived cell lines showed reduced proliferative potential in culture and displayed elevated levels of DNA damage, as measured by 53BP1 and gH2AX foci accumulation under non-challenging conditions (Figures S5A-S5C ). Immunoblotting revealed that both P1 and P2 patient-derived cell lines showed a strong decrease in the levels of POLE1, and a significant reduction in the levels of POLE2, but not POLE3 and POLE4 ( Figures 4A and 4B ). Other replisome components were unaffected in both cell lines either in total or À/À and Pole4 +/+ cells were subjected to IR or HU (hydroxyurea) treatment, with the described doses, and cell viability was assessed after 5 days (ns, not significant; *p < 0.05; **p < 0.01; ****p < 0.0001); error bars ± SD are included.
(legend continued on next page) in chromatin extracts. Notably, we observed a stronger reduction in POLE1 levels, compared to that previously reported in POLE1 patient-derived lymphoblastoid cell lines (Pachlopnik Schmid et al., 2012) , which may explain the more severe growth failure observed in P1 and P2 heights. Analysis of replication fork parameters revealed that POLE1 patient cells showed a significant increase in asymmetric forks ( Figure 4C ) and an accumulation of longer, newly incorporated nucleotide tracts ( Figure 4D ). IOD distribution was also significantly different between non-affected and affected patient cells, with the latter presenting with significant increased IOD (Figure 4E) . Consistent with this, the overall percentage of initiation events was significantly reduced in the affected patient cells (Figures 4F and 4G ). These data reveal striking similarities between Pole4-deficient MEFs and human POLE1 mutant cells and suggest a common pathogenic mechanism, potentially involving impaired replication fork establishment.
Reduced Origin Activation Drives Chromosomal Instability in Polε Hypomorphic Mouse and Human Cells
We hypothesized that if Polε hypomorphic mouse and human patient cells are compromised for origin activation, they should exhibit hydroxyurea (HU) and/or aphidicolin (Aph) sensitivity, similar to Mcm4 (Chaos3) mice and patients cells with an MCM4-NT truncation (Gineau et al., 2012; Shima et al., 2007) . Consistent with this hypothesis, Pole4 À/À cells and POLE1 patient cells were not sensitive to ionizing radiation (IR) but showed heightened sensitivity to HU compared to their WT counterparts ( Figures  5A and 5B). We reasoned that Polε hypomorphic cells might show a reduced ability to activate DNA replication origins in conditions of replication stress, such as HU treatment, and would not exhibit significant IOD reduction (Ge et al., 2007; Kubota et al., 2011) . Indeed, Pole4 +/+ MEFs and human control cells showed a very low mean IOD upon HU treatment, consistent with activation of dormant origins. On the contrary, both Pole4 À/À and POLE1 patient cells showed higher IOD values when challenged with HU, which is consistent with inefficient origin activation ( Figures 5C-5E ).
To analyze the consequences of reduced origin activation upon replication stress, we exposed WT and Pole4 À/À cells, as well as control and patient cells, to low Aph doses for 24 hr and analyzed chromosome spreads by Giemsa staining. As shown in Figures 5F and 5G , under unchallenged conditions we failed to detect signs of chromosomal instability in Pole4
and POLE1 mutant cells. However, treatment with low Aph dose resulted in a dramatic increase in the frequency of chromosome breaks and rearrangements in Polε hypomorphic cells ( Figures 5F and 5G ). Together, these data imply that inefficient origin activation underlies the replication stress response and DNA damage accumulation in Polε hypomorphic mouse and human patient cells.
p53 Deficiency Rescues Embryonic Lethality and Drives Tumorigenesis in Pole4 -/-Mice Since Pole4 null embryos and mice exhibit elevated levels of apoptosis, we proceeded to test the impact of p53 loss on the viability and phenotype of Pole4-deficient mice. Strikingly, loss of one or both alleles of p53 was sufficient to rescue the embryonic lethality of Pole4 mutant mice in the inbred C57BL/6 background ( Figure S6A ). In contrast to Pole4 À/À mice, which are essentially embryonic lethal in this inbred background, doublemutant mice were born at submendelian ratios (3.7% born versus 6.25% expected), were devoid of gross abnormalities, and displayed a similar size as WT littermate controls ( Figures  6A and S6B) . Furthermore, the loss of coordination, observed in rotarod experiments, associated with Pole4 deficiency was partially rescued by removing both p53 alleles, but not by a single copy of p53 ( Figure 6B ). Loss of both p53 alleles also rescued the absolute number and proportion of white blood cells (Figure 6C ). Flow cytometry analysis revealed that the numbers of T cells (CD4 + and CD8 + ) and B cells in the double mutants were restored to levels comparable to Pole4 +/+ p53 À/À mice (Figures 6D and 6E ). Together, these data establish that p53 loss rescues most of the phenotypes that occur in Pole4-deficient mice. We showed in Figures 1 and S1 that Pole4 deficiency triggers p53 activation during embryogenesis and is associated with lymphoma development. For this reason, we sought to examine the functional interaction of Pole4 and p53 in lymphoma incidence. To this end, we monitored cohorts of Pole4
, and Pole4 À/À p53 À/À mice for $18 months and performed a Kaplan-Meier analysis to assess lymphoma-free survival ( Figure 6F ). Strikingly, removal of a single p53 allele in Pole4-deficient mice significantly reduced lymphoma-free survival from 480 days in Pole4 +/+ p53 +/À mice to 226 days in Pole4 À/À p53 +/À mice. Furthermore, $90% of Pole4 À/À p53 +/À mice presented with lymphomas ( Figure 6G ), suggesting that haploinsufficiency for p53 contributes to lymphomagenesis in the absence of POLE4. These data also suggest that Pole4 À/À mice are specifically prone to lymphoma development since p53 +/À mice more frequently develop epithelial cancers (Jacks et al., 1994) . Collectively, these data establish (B) POLE1 mutant (P1 and P2) and control (CTR1 and CTR2) cells were subjected to IR or HU (hydroxyurea) treatment, with the described doses, and cell viability was assessed after 5 days (ns, not significant; **p < 0.01; ***p < 0.001); error bars ± SD are included. (C) Upper: representative scheme of the hydroxyurea treatment and CldU-IdU labeling scheme used for fiber stretching assay. Lower: representative images of inter-origin distances (IODs) from Pole4 +/+ and Pole4 À/À cells. Scale bar, 5 mM. (legend continued on next page) that loss of p53 is able to rescue viability and growth of Pole4-deficient mice but increase lymphomagenesis.
DISCUSSION
Polε is a fundamental component of the eukaryotic replisome and mutations of its subunits lead to human genetic disease and cancer (Campbell et al., 2017; Frugoni et al., 2016; Kandoth et al., 2013; Pachlopnik Schmid et al., 2012; Yang et al., 2013) . Despite this, the lack of functional and genetic studies on Polε in mammals has limited our understanding of its role in complex organisms. Here, we present the first detailed genetic and mechanistic characterization of mammalian Polε using a mouse knockout and human patient-derived cell lines, which has revealed key roles for Polε during development and in human pathology.
Analysis of embryonic fibroblasts and tissue extracts from Pole4
À/À mice revealed that POLE4 is required to maintain the stability of the whole Polε complex. Together with the finding that POLD3 is important for Pold complex stability, our results suggest an important structural role for the accessory subunits of replicative polymerases in mammals (Murga et al., 2016) . Despite the strong reduction in total protein levels of Polε, biochemical and proteomic characterization of Pole4 À/À MEFs showed no significant change in the levels of POLE1 and POLE2 at active replication forks. These data suggest that a POLE1-POLE2 subcomplex is sufficient to initiate and sustain DNA replication in mammalian cells. At the molecular level, Pole4 À/À MEFs exhibit increased fork rates and larger inter-origin distances associated with accumulation of fork stalling events. This phenotype can be explained by an overall reduction in DNA replication origin activation and excludes defective fork elongation as the initial trigger of replication stress. This also implies that the POLE3-4 subcomplex is dispensable for maintaining normal fork rates in mammalian cells, at least under unchallenged conditions, which differs from what has been observed in S. cerevisiae both in vivo and in vitro (Aksenova et al., 2010) . We note that a similar phenotype has been described in MEFs derived from Mcm4 (Chaos3) mice (Kawabata et al., 2011a; Shima et al., 2007) . While levels of chromatin-bound MCMs are unaffected in our model, Pole4 À/À MEFs showed a similar inability to activate replication origins under conditions of replication stress and a striking sensitivity to replication inhibitors, such as Aph, which results in significant chromosomal instability. We speculate that, in Pole4-deficient cells, the levels of Polε are sufficient to sustain normal DNA replication in most tissues and cellular compartments, while the particular dynamics of embryonic replicative cycles and lymphocytes precursor proliferation might affect genome replication and its stability.
Human cell lines derived from patients harboring destabilizing POLE1 mutations showed similar replication profiles, defective origin activation, and severe sensitivity to replication inhibitors to that observed in Pole4-deficient MEFs. Similar cellular phenotypes have also been described in cell lines derived from patients affected by mutations of GINS1 and an MCM4-NT truncation (Cottineau et al., 2017; Gineau et al., 2012) . We speculate that all these conditions share a common defect in origin activation at the crossroad of CMG helicase formation and/or activation. In our Polε hypomorphic cells, we detected an altered stoichiometry in the chromatin-bound levels of Polε and CMG components, such as GINS subunits and CDC45. This was particularly evident in the C57BL/6 inbred background, which showed greatly reduced levels of PCNA and Pold subunits on chromatin fraction (suggesting reduced active forks) despite minimal changes in CDC45 and GINS subunits. While CDC45 has been documented to bind to MCMs very early during S-phase and independently from the GINS complex, in vitro and in vivo data in S. cerevisiae have shown that Polε is required for stable CMG formation (Handa et al., 2012; Muramatsu et al., 2010; Sengupta et al., 2013; Yeeles et al., 2015) . Here, we establish that chromatin binding of GINS components might not be compromised by reduced Polε levels as recently reported by Miyazawa-Onami et al. using a Pol2 degron strategy (Miyazawa-Onami et al., 2017). While we cannot exclude the possibility of defective stable CMG formation, our data show that Polε is required for initiation of DNA replication in mammalian cells. A role for the budding yeast Polε complex in epigenetic inheritance at the replication fork has been suggested by telomeric silencing defects (Iida and Araki, 2004) . Recently, the Dpb3-Dpb4 subcomplex has been directly linked to this phenomenon (He et al., 2017) . Future studies will be needed to address a possible role for human Polε and its smallest subunits in histones recycling and/or deposition at the replication fork.
At the organismal level, Pole4-deficient mice suffer from intraand extra-uterine growth retardation, severe developmental abnormalities, lymphopenia, and lymphomagenesis. The growthretardation phenotype, craniofacial and skeletal abnormalities, and reduction in T and B cell levels closely parallel the clinical phenotypes associated with reported mutations of POLE1 and POLE2 in humans, despite the obvious anatomical differences between mice and humans (Frugoni et al., 2016; Pachlopnik Schmid et al., 2012; Thiffault et al., 2015) . Similar anomalies with selective immunodeficiencies and growth restriction have also been described in patients with hypomorphic mutations in GINS1 and a N-terminal truncation of MCM4 (not affecting MCM2-7 chromatin levels), which suggests a common pathogenetic mechanism affecting initiation of DNA replication (Cottineau et al., 2017; Gineau et al., 2012; Hughes et al., 2012) . Notably, the phenotype for this group of genes appears distinct (E) Representative flow cytometry plots of Pole4/p53 mice spleen gated on B lymphocytes and demonstrating a similar number CD19 + and IgD À cells. At least three animals have been analyzed per condition, and analyses were done in triplicates.
(F) Lymphoma-free survival of Pole4/p53 mice. n = 16 Pole4
, n = 13 Pole4
. Significance: Mantel-Cox test; Pole4
, p = 0.0746. Mice culled due to nonspecific phenotypes (e.g., dermatitis, overgrown teeth, and fits) were excluded from this study. (G) Lymphoma frequency of Pole4/p53 mice. Significance: Fisher's exact test; Pole4
, p = 0.0051; Pole4
from Meier-Gorlin syndrome (a form of microcephalic dwarfism with microtia and patella hypoplasia/aplasia), which is caused by mutations in genes encoding the pre-replication (PRE-RC) components ORC1,4,6, Cdc6, and Cdt1; Geminin, and the pre-initiation complex (PRE-IC) component CDC45 (Bicknell et al., 2011a; Bicknell et al., 2011b; Fenwick et al., 2016; Guernsey et al., 2011) . Our analysis of Pole4-deficient mice suggests that B and T cell development is affected at its initial step, such as the doublenegative stage of T cell maturation. Double-negative T cells originate from common precursors migrating from the bone marrow. While having lost self-renewing abilities, double-negative cells undergo a significant proliferative burst in the thymus environment before undergoing successive commitment toward CD4 or CD8 expression (Koch and Radtke, 2011) . We suspect that this stage is particularly vulnerable to replication stress due to inefficient origin activation. Consistent with this, previous POLE1 patients did not show alteration of T cell receptor (TCR) repertoire or immunoglobulin distribution, while switched B cells and memory B cells were equally affected in their total levels, which exclude immunoglobulin G (IgG) and TCR rearrangement defects (Pachlopnik Schmid et al., 2012) .
Most of the developmental phenotypes observed in embryos and adult Pole4 À/À mice likely reflect the consequence of activation of a p53-dependent apoptotic cascade (Figures 1, 2 , and 6). Indeed, genetic ablation of p53 in Pole4 À/À animals is sufficient to rescue the plethora of developmental and immunological defects observed in these mice. These data suggest that embryonic replicative stress is the major driver of the phenotypes described in Pole4 À/À adult mice and, most likely, in humans suffering hypomorphic mutations of Polε and/or CMG components. Consistent with the important tumor suppressor function of p53, rescue of T and B cell maturation was associated with an increased susceptibility to lymphoma development as observed in Pole4 À/À p53 +/À mice.
In conclusion, our analysis of Polε hypomorphy provides a molecular understanding for a new group of genetic conditions at the crossroad of CMG helicase activation. We also provide evidence for an essential role for controlled CMG helicase and origin activation in embryonic development, genome stability, and tumor suppression.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents should be directed to and will be fulfilled by the Lead Contact, Simon Boulton (simon. boulton@crick.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse strains
Mice deficient for POLE4 were generated using an VGB6 ES cell line Pole4 tm1(KOMP)Vlcg available from KOMP repository (University of California, Davis) in which a deletion cassette containing a b-Galactosidase and a neomycin resistance was inserted in exon 1. This ES line is heterozygous for the Pole4 tm1(KOMP)Vlcg insertion and therefore contains a WT allele of POLE4, which is sufficient to provide normal function of Polε based on our analysis in het MEF lines. The precise localization of the genetrap vector has been determined by sequencing using primer 5 0 -AAACCGCACTTCCAATTCTG-3 0 . Pole4 tm1(KOMP)Vlcg ES cells were injected into C57BL/6Jax host blastocysts and implanted into pseudopregnant females. Chimeric mice were obtained and bred to C57BL/6Jax mice. The resulting heterozygous (Pole4 +/À ) mice were bred to obtain homozygous Pole4
. Genotyping of the offspring was confirmed by western-blot using a homemade antibody and PCR using the following primers (P4-common, 5 0 -GAGAGGCGTGGTCTCTACCC-3 0 ; P4-WT, 5 0 -CACCAAGGCCTTTACTCTCG-3 0 ; P4-mut 5 0 -ATCTCTCCTCTGCAGGACCA-3 0 ). Homozygous Pole4 À/À mice were also bred into an oubred background 129X1/SvJ;129S1/Sv; FVB/N. Trp53 tm1Brd were obtained from Allan Bradley (Donehower et al., 1992) .
Homozygous Pole4 À/À mice were bred to Trp53 À/À to obtain double heterozygous mice that were mated together to produce MEFs and double homozygous mice.
reduction in post-natal stature. Immunodeficiency, adrenal failure, and male genital hypoplasia were present in some, but not all cases. The molecular genetic identification of POLE1 mutations and the detailed clinical phenotype of all 8 cases will be documented in a separate manuscript (C.L., J.E. Murray et al., unpublished data). Patient 1, was noted to have intrauterine growth retardation at 18/40 gestation on routine ultrasonography, and at birth weighed 926 g (born at 31 weeks gestation). At age 18; height 109.9cm, À9.6 standard deviations (s.d.) below the mean, head circumference À5.1sd. He has low-set posteriorly rotated ears, a small chin, and long thin nose with short neck. He has had CMV pneumonitis, and an EBV-driven hemophagocytic lymphohistiocytosis that resulted in bone marrow transplant. CD4 lymphopenia and hypogammaglobinemia were evident prior to transplantation. He has also had endocrinological complications with primary adrenal failure, hypopituitarism, and insulin resistance. He had also a younger sister who died of HSV infection.
Patient 2 was born at term with a birth weight of 2.5kg. At age 7, height was 93.8cm, À5.4sd; head circumference À2.7sd. He has a similar facial appearance to P1, with small low-set ears, micrognathia, and down-slopping palpebral fissures. No increased susceptibility to infections or immunodeficiency has been reported to date, although he has suffered from recurent otitis media associated with conductive hearing loss. He has recently acquired hearing aids. He also has primary adrenal failure (glucocorticoid deficiency), an accessory central tooth (extracted), a history of severe infantile eczema, cryptorchidism and hypospadias, and severe feeding difficulties due to oral aversion alongside a moderate learning disability. He also has documented osteopenia. Molecular Genetics of POLE1 patients Patient 1 is compound heterozygous for the truncating mutation, c.2010dupC, p.Phe672Valfster11, and the intronic variant, c.1686+32C > G.
Patient 2 is compound heterozygous for the same intronic variant, c.168+32C > G in conjunction with an essential splice site mutation, c.62+1G > A.
RT-PCR analysis of patient RNA and in vitro mini-gene splicing studies have established that the +32 intronic variant significantly impairs splicing of intron 15, resulting in retention of 47bp intronic sequence, that results in a frameshift consequently predicted to result in nonsense-mediated decay (manuscript in preparation, CL, JM, APJ). Molecular genetic findings predict substantial reduction of POLE1 protein levels and impaired Pol-epsilon function in both patients.
Footnote: Sequence variants annotated on the basis of reference sequence NM_006231.3/NP_006222.2
METHOD DETAILS
Mice breeding and experiments At least 3 breedings were continuously mated to establish Mendelian ratios and fertility. For longevity studies, mice were allowed to age and observed for development of disease. The endpoint of the study was set at 21 months but if they appeared unhealthy or got palpable tumors beforehand, animals were sacrificed. They were then subjected to full necropsy.
For blood sampling, mice were placed in a heating chamber for 10 minutes. Then, tail prick was performed and blood was collected into EDTA coated end-to-end capillaries (Sarstedt, 19.447 ) and transferred to EDTA coated microvettes (Sarstedt, 20.1278) . 10ml of blood (duplicates) was used to perform a full blood differential on the VetABC+ blood analyzer (Horiba).
All animal experimentations were undertaken in compliance with UK Home Office legislation under the Animals (Scientific Procedures) Act 1986.
Histology, immunohistochemistry
For histology and post-mortem tissues, samples were fixed in 10% Neutral buffered formalin (NBF), paraffin embedded, sectioned at 4mm and stained with hematoxylin and eosin.
For immunohistochemistry, samples were prepared using standard methods. In brief, tissue sections were processed for staining by microwaving in 0.01M citrate buffer, pH 6. After incubation with primary antibodies (PLZF, Santa Cruz sc28319; p53, Vector VP-P596; Cleaved Caspase3, Cell Signaling 9664; gH2AX, Millipore 05-636;), samples were incubated with biotinylated secondary antibody (Vector) followed by incubation with Avidin Biotin Complex (Vector, Biotinylated Goat anti-rabbit IgG BA-1000; Biotinylated Horse anti-Mouse (Rat adsorbed) BA-2001); slides were developed in 3,3 0 -diaminobenzidine (DAB) substrate (Vector, SK-4100) and counterstained in hematoxylin. Embryos section images were acquired at 40X using a Aperio AT2 scanner (Leica). Stainings were quantified using Cell Profiler software. Testis and lymphomas section images were acquired at 20X using an Axio Scan.Z1 (Zeiss) and stainings were quantified using ImageJ software on serial sections and tubules with similar diameter.
Alcian blue/Alizarin red staining Embryos were stained following a modified version of the protocol published by Rigueur and Lyons, 2014. Briefly, embryos were collected at 15.5dpc and extraembryonic membranes were removed. Then embryos were fixed overnight in 70% ethanol at room temperature and incubated in 95% ethanol for 1 h. Ethanol was replaced by acetone to remove excess of fat and let overnight at room temperature. Embryos were then stained with 0.03% Alcian Blue (Sigma, A5268) for 24h and then de-stained in 70% ethanol overnight. They were cleared in 1% KOH for 3h and then counterstained in 0.05% Alizarin Red S (Sigma, A5533) for 4h at room temperature. Embryos were cleared in 1% KOH overnight and then transferred to 100% glycerol for long-term storage.
Pictures were taken on a white background using a Stemi SV6 stereomicroscope (Zeiss) and bone were measured using ImageJ software.
MicroCT scan
Mice were anaesthetized with 2.5% isofluorane and microCT images were taken using a SkyScan 1176 microCT scanner (Bruker Micro CT, Kontich, Belgium). Anaesthesia was maintained with 2% isoflurane during the scan. X-ray projection images were acquired using a source voltage of 50kV and a source current of 500mA and a 0.5mm aluminum filter over a 180 trajectory with a rotation step size of 0.7
. Other imaging parameters were: pixel size = 36.04mm, frame averaging = 2, exposure time = 60ms. Scan time was 3min 35sec per sub scan. Each lower body scan consists of 6 sub scans. Reconstruction was performed using NRecon software (version 1.6.8) Reconstruction parameters: smoothing set to 4, ring artifact correction set to 4 and beam hardening correction set to 35%. A variable post alignment compensation and dynamic range of 0.001973-0.092057 of the X-ray attenuation coefficient were applied.
Rotarod experiments
Animals in home cage were placed in testing room for at least 1hr before testing to minimize effects of stress on behavior during testing. Animals from the same cage were placed in separated lane of the apparatus (AccuRotor 4-Channel RotaRod) and trained to walk on a 5rpm rotating rod for 60 s (3 trials separated by 10 min intervals). Then animals were placed on the rod again and the apparatus was set to accelerate from 4 to 40rpm in 300 s. Procedure was repeated 3 times separated by at least 10 min intervals. Any animals that completed a full passive rotation around the rod were trialed a fourth time. The latency to fall was recorded and plotted on graphs. Young animals were tested at 3-4 months old and aged animals around 12 months old. Body weight was checked to ensure that it won't affect their gait.
Cobblestone area forming cell assay (CFAC) 2x10 5 bone marrow cells were plated (in triplicates) for colony-forming assay using MethoCult (StemCell Technologies, M3434) following the manufacturer's instructions. Cells were incubated at 37 C with 5% CO2 and 20% O2 for 12 days, before colonies were identified and counted manually as CFU (Colony Forming Unit) -G (Granulocytes), -M (Macrophages), -GM (Granulocyte, Macrophage), GEMM (Granulocyte, Erythroid, Macrophage, Megakaryocyte), BFU-E (Burst Forming Unit-Erythroid).
Chromosome spreads and GIEMSA staining Cells in mid-exponential phase of growth were incubated in colcemid (10 mg/ml) for 2-4 hours. After shake off, floating cells were collected, pelleted and resuspended in 2 mL of media. Upon addition of 4 mL of deionized water, cells were gently mixed and incubated for 6 min at R.T. before being fixed on ice in methanol/acetic acid (3:1). Fixed cells were washed again in fixative buffer and resuspended 200 mL of fresh fixative buffer and spreaded on clean slides by gentle dropping. Dried slides were subsequently incubated in a solution of 6% GIEMSA/PBS for 7 min, washed in PBS and deionized water. Slides were finally mounted with DPX mounting media and analyzed using Axio Imager.M2 (ZEISS) with 60x oil immersion objective and the Volocity 6.3 software.
iPOND (isolation of Proteins on Nascent DNA) and iPOND SILAC Mass Spect iPOND was performed according to standard protocols (Sirbu et al., 2011) . Pole4 +/+ and Pole4 À/À MEFs were pulse labeled with 10 mM EdU (5-ethynyl-2 0 -deoxyuridine, Invitrogen) for 10 min. After washing in normal media, cells were released or not for 30 min in media containing 10 mM thymidine (SIGMA). Cells were then fixed in 1% Formaldehyde (SIGMA) in PBS for 20 min at R.T. Crosslinking was subsequently quenched by addition of Glycine to a final concentration of 0.125M for 10 min at R.T. Cells were scraped, pelleted, washed 3 times in PBS and stored at À80. Frozen pellets were resuspended in 0.25% Triton/PBS and incubated at R.T. for 30 min. After washing in 0.5% BSA/PBS and PBS, pellets were resuspended in Click reaction cocktail cointaining 10 mM Biotin-Azide (Invitrogen), 10 mM Na Ascorbate (SIGMA) and 2mM CuSO4 (SIGMA) and incubated for 1h at R.T. Controls were resuspended in the same buffer containing DMSO instead of Biotin-Azide. After washing in 0.5% BSA/PBS and PBS, pellets were lysed in RIPA buffer (150 mM NaCl, 100 mM Tri pH 7.5, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycolate) containing protease and phosphatase inhibitors (ROCHE) and sonicated using a BIORUPTOR sonicator in 1.5 mL Eppendorf tubes (20-25 cycles at 30 s on, 30 s off setting). Lysates were clarified by high speed centrifugation (13.200 rpm, 15 min at 4 C) and incubated with streptavidin Sepharose beads (GE Healthcare) for 16 hours. After being washed in RIPA and 1M NaCl, beads were resupended in 2X Laemmli buffer, incubated for 25 min at 99 C and loaded on 4%-12% NUPAGE Bis-Tris gels for SDS-PAGE analysis. ]l-lysine (heavy) with 200 mg/L l-proline, at passage 0, amplified to passage 2 and subjected to iPOND as previously described. To this aim, cells grown in heavy and light media were fixed, quenched and collected in the same tube to obtain a single mix. After iPOND, pellet lysis in RIPA, samples sonication and streptavidin beads capture, the immunoprecipitated material was subjected to SDS-PAGE. Coomassie-stained polyacrylamide gel slices were excised from SDS-PAGE gels using a scalpel into a 96 well plate and processed for mass spectrometry using the Janus liquid handling system (PerkinElmer). Briefly, the excised protein gel pieces were placed in individual wells of a 96-well microtiter plate and destained with 50% v/v acetonitrile and 50 mM ammonium bicarbonate, reduced with 10 mM DTT, and alkylated with 55 mM iodoacetamide. After alkylation, the samples were digested with trypsin (Promega), overnight at 37 C. The resulting peptides were extracted in 1% v/v formic acid, 2% v/v acetonitrile. Digests were subsequently analyzed by nano-scale capillary LC-MS/MS. Peptide mixtures were separated on a 50 cm, 75um I.D. EasySpray C 18 LC-MS column over a 30 minutes gradient and eluted directly into the LTQ Orbitrap Velos or Orbitrap Fusion Lumos (Thermo Scientific) mass spectrometer. The mass spectrometer was operated in data dependent mode with the most intense multiply charged precursor ions fragmented in the linear ion trap using collision-induced dissociation. Raw mass spectrometric data was processed in MaxQuant (Nature Biotechnology 26, 1367 Biotechnology 26, -1372 Biotechnology 26, (2008 ) (version 1.5.2.8) for protein identification and SILAC quantification, the database search was performed using the Andromeda search engine against the Mus musculus canonical sequences downloaded from UniProtKB (release 2012_08).
POLE4 Antibody generation
Policlonal anti-POLE4 antibody was generated by immunizing rabbits with full length un-tagged human POLE4 obtained by standard E. Coli expression methods. Serum was affinity purified by chromatography using a GST-POLE4 column and used at a 1:1000 concentration for western blotting. Rabbits immunization and antibody purification was performed by Cambridge Research Biochemicals (Billingham, UK) in accordance with standard rules and procedures.
Analysis of Hydroxyurea and Ionizing radiation sensitivity
Pole4
+/+ and Pole4 À/À MEFs as well as POLE1 mutant and control cells were treated with increasing doses of Hydroxyurea (SIGMA)
for 24 hours or irradiated using a GSR D1
137
Cs irradiator with 2 or 4 Gy. After washing, cells were left growing in standard media for 5 days and viable cells were analyzed using Cellometer Auto 2000 (Nexcelom Bioscience).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistics, including statistical tests used, number of events quantified, standard deviation standard error of the mean, and statistical significance are reported in the figures and in the figure legends (Kaplan-Meier plots for survival and significance calculation using Log-rank (Mantel-Cox) test, unpaired t test for staining quantification statistics). Statistical analysis has been performed using GraphPad Prism7 software (GraphPad) and statistical significance is determined by the value of p < 0.05.
